NCT06416293 Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians
| NCT ID | NCT06416293 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital Augsburg |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-04-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2022-04-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this BZKF project is to record the current care structure for breast cancer patients in order to use this as a basis for developing possible future models for improvement. The active involvement of representatives of regional and national patient organizations in the creation of a patient-based and patient-oriented survey ensures that the needs of patients are the focus. In addition to and in contrast to other projects, relevant questions are explicitly addressed not only to patients but also to physicians in order to identify and specify the interfaces between patient wishes/suggestions and to develop clinical consequences for care. The first objective is to survey the "current situation" by recording the current care structure for breast cancer. The focus is on the survey of both groups on patient-physician communication, time management and coping strategies. By planning the future harmonization of national data structures, the basis is created for the long-term goal of an improved "target", a concept developed jointly by physicians and patients for an improved communication and care structure that focuses on the patient.
Eligibility Criteria
Inclusion Criteria (patients): * Breast cancer or DCIS * women and men aged 18 years and older Exclusion Criteria (patients): * women and men \< 18 years * no histologically confirmed breast cancer or DCIS diagnosis Inclusion Criteria (physicians): \- Treatment of breast cancer patients
Contact & Investigator
Nina Ditsch, Prof.
PRINCIPAL INVESTIGATOR
University Hospital Augsburg
Frequently Asked Questions
Who can join the NCT06416293 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06416293 currently recruiting?
Yes, NCT06416293 is actively recruiting participants. Contact the research team at nina.ditsch@uk-augsburg.de for enrollment information.
Where is the NCT06416293 trial being conducted?
This trial is being conducted at Augsburg, Germany.
Who is sponsoring the NCT06416293 clinical trial?
NCT06416293 is sponsored by University Hospital Augsburg. The principal investigator is Nina Ditsch, Prof. at University Hospital Augsburg. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.